MedPath

Exercise rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy: Impact and mechanisms

Not Applicable
Recruiting
Conditions
cancer
chemotherapy-induced peripheral neuropathy
Cancer - Any cancer
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Public Health - Health service research
Registration Number
ACTRN12619001093178
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

1.Grade 2 or 3 chemotherapy-induced peripheral neuropathy (symptoms affecting function)
2.At least 3 months post-neurotoxic cancer treatment and not planned for neurotoxic cancer treatment in the next 8 weeks
3.Previously treated with cancer treatments for which neuropathy is a known side effect
4.Greater than 18 years of age
5.Able to provide written informed consent
6.Cleared by a physician to participate in a structured exercise program

Exclusion Criteria

1.Eastern Cooperative Oncology Group (ECOG) performance status equal to or greater than 3
2.Patients with known peripheral neuropathy prior to neurotoxic cancer treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of a clinic exercise intervention with usual care on chemotherapy-induced peripheral neuropathy symptoms using The Total Neuropathy Score, clinical (TNSc).<br><br>[Baseline, Week 8 (post-intervention; primary endpoint), 6 month post-intervention follow-up];To compare the effect of a clinic exercise intervention with usual care on patient function including The 6-minute walk test [Baseline, Week 8 (post-intervention; primary endpoint), 6 month post-intervention follow-up];To compare the effect of a clinic exercise intervention with usual care on patient function including postural sway assessment (using Swaymeter).[Baseline, Week 8 (post-intervention; primary endpoint), 6 month post-intervention follow-up]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath